Related Experiment Video
Updated: Jul 5, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Phosphorylation of cyclin dependent kinase 4 on tyrosine 17 is mediated by Src family kinases
Nicholas G Martin1, Peter C McAndrew, Paul D Eve
1Centre for Cancer Therapeutics at The Institute of Cancer Research, Cancer Research UK, Haddow Laboratories, 15 Cotswold Road, Sutton, Surrey, UK.
Abstract:
Cyclin dependent kinase 4 is a key regulator of the cell cycle and its activity is frequently deregulated in cancer. The activity of cyclin dependent kinase 4 is controlled by multiple mechanisms, including phosphorylation of tyrosine 17. This site is equivalent to tyrosine 15 of cyclin dependent kinase 1, which undergoes inhibitory phosphorylation by WEE1 and MYT1; however, the kinases that phosphorylate cyclin dependent kinase 4 on tyrosine 17 are still unknown. In the present study, we generated a phosphospecific antibody to the tyrosine 17-phosphorylated form of cyclin dependent kinase 4, and showed that this site is phosphorylated to a low level in asynchronously proliferating HCT116 cells. We purified tyrosine 17 kinases from HeLa cells and found that the Src family non-receptor tyrosine kinase C-YES contributes a large fraction of the tyrosine 17 kinase activity in HeLa lysates. C-YES also phosphorylated cyclin dependent kinase 4 when transfected into HCT116 cells, and treatment of cells with Src family kinase inhibitors blocked the tyrosine 17 phosphorylation of cyclin dependent kinase 4. Taken together, the results obtained in the present study provide the first evidence that Src family kinases, but not WEE1 or MYT1, phosphorylate cyclin dependent kinase 4 on tyrosine 17, and help to resolve how the phosphorylation of this site is regulated.
Insights
Src family kinases, not WEE1 or MYT1, phosphorylate cyclin-dependent kinase 4 at tyrosine 17. This finding clarifies regulation of cyclin-dependent kinase 4 (CDK4) activity, a key cell cycle regulator often altered in cancer.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- Cyclin-dependent kinase 4 (CDK4) is a critical regulator of the cell cycle.
- Deregulation of CDK4 activity is common in various cancers.
- The phosphorylation of CDK4 at tyrosine 17 (pY17) is a known regulatory mechanism, but the responsible kinases were unidentified.
Purpose of the Study:
- To identify the kinases responsible for phosphorylating cyclin-dependent kinase 4 (CDK4) at tyrosine 17.
- To elucidate the regulatory mechanisms controlling CDK4 activity through pY17 phosphorylation.
Main Methods:
- Generation of a phosphospecific antibody for pY17-CDK4.
- Purification of tyrosine 17 kinases from HeLa cell lysates.
- In vitro kinase assays and cell transfection experiments.
- Treatment with Src family kinase inhibitors.
Main Results:
- Tyrosine 17 of CDK4 is phosphorylated at low levels in proliferating HCT116 cells.
- The Src family kinase C-YES was identified as a major contributor to pY17-CDK4 activity in HeLa cells.
- C-YES directly phosphorylated CDK4 at Y17 in transfected cells.
- Inhibition of Src family kinases reduced pY17-CDK4 levels in cells.
Conclusions:
- Src family kinases, including C-YES, are the primary kinases phosphorylating CDK4 at tyrosine 17.
- WEE1 and MYT1 do not phosphorylate CDK4 at this site.
- This study clarifies the regulation of CDK4 activity via Y17 phosphorylation, offering insights into cancer-related signaling pathways.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
MAPK Signaling Cascades
Anaphase Promoting Complex
Receptor Tyrosine Kinases
Inhibition of Cdk Activity